Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists
Blustein, Pegah, Werner, Sarah R., Uppalapati, Pooja, Leung, Tung Ming, Husk, Gregg A., Pereira, Elena B., Whyte, Jill S., Villella, Jeannine A.
Published in American journal of obstetrics and gynecology (01.09.2023)
Published in American journal of obstetrics and gynecology (01.09.2023)
Get full text
Journal Article
Regular Analgesic Use and Risk of Endometrial Cancer
MOYSICH, Kirsten B, BAKER, Julie A, RODABAUGH, Kerry J, VILLELLA, Jeannine A
Published in Cancer epidemiology, biomarkers & prevention (01.12.2005)
Published in Cancer epidemiology, biomarkers & prevention (01.12.2005)
Get full text
Journal Article
Role of prophylactic hysterectomy in patients at high risk for hereditary cancers
Villella, Jeannine A., Parmar, Madhu, Donohue, Kathleen, Fahey, Cathy, Piver, M. Steven, Rodabaugh, Kerry
Published in Gynecologic oncology (01.09.2006)
Published in Gynecologic oncology (01.09.2006)
Get full text
Journal Article
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Herzog, Thomas J, Armstrong, Deborah K, Brady, Mark F, Coleman, Robert L, Einstein, Mark H, Monk, Bradley J, Mannel, Robert S, Thigpen, J. Tate, Umpierre, Sharee A, Villella, Jeannine A, Alvarez, Ronald D
Published in Gynecologic oncology (01.01.2014)
Published in Gynecologic oncology (01.01.2014)
Get full text
Journal Article
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
Berinstein, Neil L, Karkada, Mohan, Oza, Amit M, Odunsi, Kunle, Villella, Jeannine A, Nemunaitis, John J, Morse, Michael A, Pejovic, Tanja, Bentley, James, Buyse, Marc, Nigam, Rita, Weir, Genevieve M, MacDonald, Lisa D, Quinton, Tara, Rajagopalan, Rajkannan, Sharp, Kendall, Penwell, Andrea, Sammatur, Leeladhar, Burzykowski, Tomasz, Stanford, Marianne M, Mansour, Marc
Published in Oncoimmunology (03.08.2015)
Published in Oncoimmunology (03.08.2015)
Get full text
Journal Article
Rhabdomyosarcoma of the cervix in sisters with review of the literature
Villella, Jeannine A, Bogner, Paul N, Jani-Sait, Sheila N, Block, Anne Marie W, Lele, Shashikant
Published in Gynecologic oncology (01.12.2005)
Published in Gynecologic oncology (01.12.2005)
Get full text
Journal Article
Usual adult body mass index is not predictive of ovarian cancer survival
MOYSICH, Kirsten B, BAKER, Julie A, MENEZES, Ravi J, JAYAPRAKASH, Vijayvel, RODABAUGH, Kerry J, ODUNSI, Kunle, BEEHLER, Gregory P, MCCANN, Susan E, VILLELLA, Jeannine A
Published in Cancer epidemiology, biomarkers & prevention (01.03.2007)
Published in Cancer epidemiology, biomarkers & prevention (01.03.2007)
Get full text
Journal Article
Comparison of Tolerance of Combination Carboplatin and Paclitaxel Chemotherapy by Age in Women with Ovarian Cancer
Villella, Jeannine A., Chaudhry, Taimur, Pearl, Michael L., Valea, Fidel, DiSilvestro, Paul A., Pollack, Simcha, Chalas, Eva
Published in Gynecologic oncology (01.09.2002)
Published in Gynecologic oncology (01.09.2002)
Get full text
Journal Article
Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary
Levine, Douglas A, Villella, Jeannine A, Poynor, Elizabeth A, Soslow, Robert A
Published in Gynecologic oncology (01.08.2004)
Published in Gynecologic oncology (01.08.2004)
Get full text
Journal Article
Are Graduating Ob/Gyn Residents Confident as Independent Gynecologic Surgeons? [11B]
Chen, Hui, Jimenez, Edward A., Chalas, Eva, Villella, Jeannine A.
Published in Obstetrics and gynecology (New York. 1953) (01.05.2016)
Published in Obstetrics and gynecology (New York. 1953) (01.05.2016)
Get full text
Journal Article
A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results
Tolcher, Anthony W., Carneiro, Benedito A., Dowlati, Afshin, Abdul Razak, Albiruni Ryan, Chae, Young Kwang, Villella, Jeannine A., Coppola, Sheryl, Englert, Stefan, Phillips, Andrew C., Souers, Andrew J., Salman, Zeena, Penugonda, Sudhir, Powderly, John D., LoRusso, Patricia
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Impact of Universal Screening Recommendation on Genetic Testing in Ovarian, Fallopian Tube, and Peritoneal Cancers [10P]
Gotimer, Kristin F., Jimenez, Edward A., Villella, Jeannine A., Chan, Kent C., Levine, Kelly, Chalas, Eva
Published in Obstetrics and gynecology (New York. 1953) (01.05.2016)
Published in Obstetrics and gynecology (New York. 1953) (01.05.2016)
Get full text
Journal Article
Clinical data from the DeCidE 1 trial: Assessing the first combination of DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with stage IIc-IV recurrent epithelial ovarian cancer
Dorigo, Oliver, Tanyi, Janos Laszlo, Strauss, James, Oza, Amit M., Pejovic, Tanja, Ghatage, Prafull, Villella, Jeannine A., Fiset, Stephan, MacDonald, Lisa Diana, Leopold, Lance, Rosu, Gabriela Nicola
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE 1 trial): T cell responses and tumor infiltration correlate with tumor regression
Tanyi, Janos Laszlo, Dorigo, Oliver, Oza, Amit M., Strauss, James Fredric, Pejovic, Tanja, Ghamande, Sharad A., Ghatage, Prafull, Villella, Jeannine A., Fiset, Stephan, MacDonald, Lisa Diana, Hrytsenko, Olga, Stanford, Marianne, Newton, Robert C, Leopold, Lance, Rosu, Gabriela Nicola
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Determination of optimal dose and treatment schedule of the immunotherapeutic vaccine, DPX-Survivac, for combination immunotherapy treatment of ovarian, fallopian tube or peritoneal cancer (OC): A phase Ib study
Villella, Jeannine A., Wilson, Michelle K., Berinstein, Neil Lorne, Karkada, Mohan, Quinton, Tara, Butler, Marcus O., Lheureux, Stephanie, Mandilaras, Victoria, Dhani, Neesha C., Weir, Genevieve, MacDonald, Lisa, Nigam, Rita, Stanford, Marianne, Mansour, Marc, Oza, Amit M.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer
Villella, Jeannine A., Wilson, Michelle K., Berinstein, Neil Lorne, Brown, Jennifer, Lheureux, Stephanie, Butler, Marcus O., Ramsahai, Janelle, Odunsi, Kunle, Karkada, Mohan, Nemunaitis, John J., Morse, Michael, Pejovic, Tanja, Bentley, James, Weir, Genevieve, MacDonald, Lisa, Stanford, Marianne, Burzykowski, Tomasz, Nigam, Rita, Mansour, Marc, Oza, Amit M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article